Dr. Magdalena G. Krzystolik is Site Director at Mass. Eye and Ear, Providence and Mass. Eye and Ear, Plainville (MA) where she specializes in the treatment and surgery of retinal diseases with clinical focus on diabetic retinopathy, retinal vein occlusions, age-related macular degeneration, and retinal detachments. Dr. Krzystolik's academic interests include anti-angiogenic treatments of retinal diseases and integrating retinal surgery into the ophthalmic graduate medical education curriculum.
Dr. Krzystolik received her MD from the Pritzker School of Medicine at the University of Chicago, followed by an ophthalmology residency at Harvard Medical School (HMS). Following graduation, she served as Chief Resident at Mass. Eye and Ear before completing a vitreoretinal fellowship there in 2000 as a Heed Fellow.
Dr. Krzystolik is a Member of the Faculty at Harvard Medical School, and a Clinical Associate Professor of Surgery at the Warren Alpert Medical School of Brown University where she lectures, supervises and mentors trainees, and conducts clinical research. She directs a retina clinic at the Providence VA Medical Center. She is a member of several professional societies including the New England Ophthalmological Society, Massachusetts Society of Eye Physicians and Surgeons, the Rhode Island Society of Eye Physicians and Surgeons, and the American Academy of Ophthalmology. Dr. Krzystolik is Director of a Clinical Fellowship in Medical Retina that will begin in July 2017.
Diseases of the retina and vitreous, anti-angiogenic treatments of retinal disease
Retina and vitreous disorders
For a full publication list, please see her CV.
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Cochrane Database Syst Rev. 2014 Aug 29;8.
Guideline-adherent aspirin use in individuals with age-related macular degeneration. Ramaswamy SG, Greenberg PB, Krzystolik MG. J Am Geriatr Soc. 2013 Jun;61(6):1033-4.
Avastin doesn't blind people, people blind people. Greenberg PB, Krzystolik MG, Tseng VL. Am J Ophthalmol. 2012 Sep;154(3):610; author reply 610-1.
Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema. Diabetic Retinopathy Clinical Research Network, Krzystolik MG, Strauber SF, Aiello LP, Beck RW, Berger BB, Bressler NM, Browning DJ, Chambers RB, Danis RP, Davis MD, Glassman AR, Gonzalez VH, Greenberg PB, Gross JG, Kim JE, Kollman C. Ophthalmology. 2007 Aug;114(8):1520-5.
Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture. Ament CS, Zacks DN, Lane AM, Krzystolik M, D'Amico DJ, Mukai S, Young LH, Loewenstein J, Arroyo J, Miller JW. Arch Ophthalmol. 2006 Jul;124(7):957-66.
Pegaptanib as an adjunctive treatment for complicated neovascular diabetic retinopathy. Krzystolik MG, Filippopoulos T, Ducharme JF, Loewenstein JI. Arch Ophthalmol. 2006 Jun;124(6):920-1.
Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O'Neill CA, Miller JW. Arch Ophthalmol. 2002 Mar;120(3):338-46.
View a complete list of publications on pubmed.gov>>